How Hepatitis Became A Hidden Epidemic In Africa
This article was originally published on The Conversation. Read the original article. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - March 10, 2017 Category: Consumer Health News Source Type: news

Chimps Can Get Ebola, Too, But Oral Vaccine May Help
THURSDAY, March 9, 2017 -- A new study shows promise for an oral vaccine to protect wild apes against the Ebola virus. The virus is a real threat to Africa's great apes -- for example, Ebola is estimated to have killed one in three wild gorillas in... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 9, 2017 Category: Journals (General) Source Type: news

Ebola vaccine tested on humans in UK trials
When the 2014 Ebola outbreak hit west Africa, the available vaccine had not been tested on humans. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 8, 2017 Category: Consumer Health News Source Type: news

Johnson & Johnson Announces Start of Clinical Trial of Ebola Vaccine Regimen in Sierra Leone
First study of Janssen's prime-boost vaccine regimen in an Ebola outbreak country (Source: Johnson and Johnson)
Source: Johnson and Johnson - February 16, 2017 Category: Pharmaceuticals Source Type: news

Disease ‘ superspreaders ’ accounted for nearly two-thirds of Ebola cases, study finds
They are called superspreaders, the minority of people who are responsible for infecting many others during epidemics of infectious diseases. Perhaps the most famous superspreader was Typhoid Mary, presumed to have infected 51 people, three of whom died, between 1900 and 1907. Now scientists studying how Ebola spread during the 2014-2015 epidemic in West Africa […]Related:Common weed could help fight deadly superbug, study findsGet the lead out: Hundreds suffer poisoning from bullet fragments in their bodiesMore than 350 organizations write Trump to endorse current vaccines’ safety (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - February 13, 2017 Category: Consumer Health News Source Type: news

WHO (World Health Organization) Vaccine Pipeline Tracker
World Health Organization. 04/13/2016 This spreadsheet tracks the vaccine pipeline for HIV, Malaria, TB, Enterics, RSV (Respiratory Syncytial Virus), Ebola, Zika, Dengue, and Priority Emerging Pathogens. Topics in the spreadsheet include Candidate Vaccine Name, Developer/Collaborators, Disease/Pathogen, Indication Goal, Platform, Immunogen, Adjuvant, Most Advanced Trial Phase, Trial Sponsor, and Start Date. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - January 28, 2017 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news

Meet Anne Schuchat, The Pro-Vaccine Researcher Who Just Took Over The CDC
This reporting is brought to you by HuffPost’s health and science platform, The Scope. Like us on Facebook and Twitter and tell us your story: scopestories@huffingtonpost.com.  function onPlayerReadyVidible(e){'undefined'!=typeof HPTrack&&HPTrack.Vid.Vidible_track(e)}!function(e,i){if(e.vdb_Player){if('object'==typeof commercial_video){var a='',o='m.fwsitesection='+commercial_video.site_and_category;if(a+=o,commercial_video['package']){var c='&m.fwkeyvalues=sponsorship%3D'+commercial_video['package'];a+=c}e.setAttribute('vdb_params',a)}i(e.vdb_Player)}else{var t=arguments....
Source: Healthy Living - The Huffington Post - January 25, 2017 Category: Consumer Health News Source Type: news

[In Depth] A half-billion-dollar bid to head off emerging diseases
In the wake of the Ebola crisis that erupted in West Africa in 2014, many public health leaders recognized that a more aggressive effort to develop vaccines could have moved a vaccine forward more quickly and prevented that outbreak from becoming an epidemic. A new organization was formed last year, the Coalition for Epidemic Preparedness Innovations (CEPI), to speed development of vaccines against emerging infectious diseases—but it had no serious financial backing. Now, CEPI has attracted nearly a half-billion dollars in funding, as it planned to announce at the World Economic Forum in Davos, Switzerland, this...
Source: ScienceNOW - January 20, 2017 Category: Science Authors: Jon Cohen Tags: Public Health Source Type: news

Global Coalition Aims To Outpace Epidemics With New Vaccines
A global coalition of governments, health specialists and philanthropists will launch a new plan on Thursday to “outsmart” future disease epidemics with a fund to prepare and create new vaccines. Stung by the devastation of West Africa’s 2014-2015 Ebola outbreak, which killed more than 11,300 people before an effective vaccine was developed, the coalition is aiming to ensure such deadly outbreaks can’t happen again. John-Arne Rottingen, interim chief executive officer of the Coalition for Epidemic Preparedness Innovations (CEPI), said it is designed as “a global insurance policy against epidem...
Source: Healthy Living - The Huffington Post - January 19, 2017 Category: Consumer Health News Source Type: news

Bill Gates: Ebola crisis handling had lack of 'clarity'
Bill Gates backs vaccine project which could prevent epidemics like Ebola spreading (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 19, 2017 Category: Consumer Health News Source Type: news

Completing the Development of Ebola Vaccines: Current Status, Remaining Challenges, and Recommendations
University of Minnesota, Center for Infectious Disease Research and Policy. 01/17/2017 This 50-page report focuses on six areas regarding Ebola vaccines: key readiness gaps, current progress on Ebola vaccines, remaining steps for the rVSV-ZEBOV vaccine, challenges for other vaccine candidates, hurdles for manufacturers, and leadership and coordination of vaccine efforts. It highlights the successfully completed field efficacy trial of the rVSV-ZEBOV Ebola virus vaccine, but it points out that, although this vaccine is furthest along the regulatory pathway, it is not yet licensed. The report offers 11 recommendations. (PDF)...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - January 18, 2017 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news

$460m pledged for vaccine initiative aimed at preventing global epidemics
Lassa, Mers and Nipah will be first diseases targeted by programme announced at Davos by coalition of governments, philanthropists and businessA coalition of governments, philanthropists and business is pledging to put money and effort into making vaccines to stop the spread of diseases that could threaten mankind – and to prevent another outbreak as devastating as the Ebola epidemic.At theWorld Economic Forum in Davos, the Norwegian, Japanese and German governments, the Wellcome Trust and the Gates Foundation announced they were putting in $460 million – half of what is needed for the first five years of the i...
Source: Guardian Unlimited Science - January 18, 2017 Category: Science Authors: Sarah Boseley Health editor Tags: Vaccines and immunisation Infectious diseases Davos Health Epidemics Medical research Business Science Society World news Source Type: news

Zika vaccine developer names new chief scientific officer
A Smyrna-based developer of vaccines against Zika, Ebola, HIV and other infectious diseases has named a new chief scientific officer. Farshad Guirakhoo was promoted to the C-suite role at GeoVax Labs Inc. from senior vice president of research and development, his title upon joining the company in 2015. The promotion was effective Jan. 1. His predecessor as CSO, company co-founder Harriet L. Robinson, will remain as chief scien tific officer emeritus, the company said in a statement. "For the past… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 3, 2017 Category: Pharmaceuticals Authors: Jessica Saunders Source Type: news

Ebola Vaccine 100% Effective in Clinical Trial
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - December 27, 2016 Category: Journals (General) Source Type: news

West Africa: New Ebola Vaccine Trial Results Offer Hope
[IPS] United Nations -A new Ebola vaccine may be the first to successfully protect against one of the world's most lethal pathogens, according to a trial involving over 11,000 participants in Guinea. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 27, 2016 Category: African Health Source Type: news

This won ’ t hurt a bit: Good news about health that was overshadowed in 2016
There was some good health news in 2016 amid the Zika virus and opioid overdoses.Related:Ebola vaccine shown to be ‘highly protective’ against deadly virus in major trialMystery of the spike in deaths between Christmas and New Year’s gets curiouser and curiouserCDC sends $184 million in Zika funding to states as Texas reports new case (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - December 26, 2016 Category: Consumer Health News Source Type: news

Breakthrough Ebola vaccine proves 'highly protective'
Amy R. ConnollyGENEVA, Switzerland, Dec. 24 (UPI) -- An experimental Ebola vaccine proved to be 100 percent effective in eradication the deadly disease when used in a major clinical trial in Guinea. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 24, 2016 Category: Consumer Health News Source Type: news

Ebola Vaccine 100% Effective in Clinical Trial Ebola Vaccine 100% Effective in Clinical Trial
An experimental Ebola virus vaccine was 100% effective, a new study has shown.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 24, 2016 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Africa: Final Trial Results Confirm Ebola Vaccine Provides 'High Protection' - UN Health Agency
[UN News] The United Nations World Health Organization (WHO) has said that an experimental Ebola vaccine has been found to be highly protective against the deadly virus in a major trial in Guinea. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 23, 2016 Category: African Health Source Type: news

Scientists Announce Ebola Vaccine
Scientists announced Thursday that they created a safe, effective vaccine to prevent Ebola. They don't know yet how long the protection will last, but it will bring outbreaks to a screeching halt. (Source: NPR Health and Science)
Source: NPR Health and Science - December 23, 2016 Category: Consumer Health News Authors: Michaeleen Doucleff Source Type: news

West Africa: Ebola Vaccine Shows 100 Percent Protection, Study Shows
[Al Jazeera] The World Health Organization (WHO) says it has developed a highly effective vaccine against the deadly Ebola virus after trials in Guinea showed it offered 100 percent protection. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 23, 2016 Category: African Health Source Type: news

Ebola Vaccine Appears Very Effective in Trial
Drug manufacturer says it will seek regulatory approval by end of 2017 (Source: WebMD Health)
Source: WebMD Health - December 23, 2016 Category: Consumer Health News Source Type: news

Ebola Vaccine Appears Very Effective in Trial
Drug manufacturer says it will seek regulatory approval by end of 2017 Source: HealthDay Related MedlinePlus Pages: Ebola, Immunization (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 23, 2016 Category: Consumer Health News Source Type: news

An opioid epidemic is what happens when pain is treated only with pills
Too many opioids. Not enough opioids. Behold the opioid paradox. The United States is in the midst of a massive opioid epidemic, as The Washington Post and other news organizations have documented extensively. In 2015, more than 33,000 people died from overdoses of opioids, meaning prescription painkillers, heroin, fentanyl or any combination. That easily keeps […]Related:Ebola vaccine shown to be ‘highly protective’ against deadly virus in major trialMystery of the spike in deaths between Christmas and New Year’s gets curiouser and curiouserCDC sends $184 million in Zika funding to states as Texas...
Source: Washington Post: To Your Health - December 23, 2016 Category: Consumer Health News Source Type: news

Ebola vaccine highly effective, WHO says
Scientists have struggled to develop an Ebola vaccine over the years, and this is the first one proven to work (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - December 23, 2016 Category: Consumer Health News Source Type: news

Ebola vaccine gives 100% protection, study finds
An experimental vaccine against the Ebola virus was found to be 100% effective, according to a study published in The Lancet on Thursday. (Source: CNN.com - Health)
Source: CNN.com - Health - December 23, 2016 Category: Consumer Health News Source Type: news

Successful Ebola vaccine will be fast-tracked for use
A high effective vaccine that protects against deadly Ebola virus could be available by 2018. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - December 23, 2016 Category: Consumer Health News Source Type: news

Ebola Vaccine Appears Very Effective in Trial
FRIDAY, Dec. 23, 2016 -- An experimental Ebola vaccine was highly effective against the deadly virus in a large trial conducted in Guinea, researchers say. The vaccine trial included nearly 12,000 people during 2015, when new cases of Ebola were... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 23, 2016 Category: Journals (General) Source Type: news

West Africa: Prototype Vaccine for Ebola Virus Proves Effective
[Deutsche Welle] A prototype vaccine for Ebola has proven effective in Guinea, according to the World Health Organization. It hopes fast-track approval will emerge by 2018. The hemorrhagic virus killed 11,300 people in western Africa. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 23, 2016 Category: African Health Source Type: news

New Ebola Vaccine Trial Results Offer Hope
Two health care workers clean their feet in a bucket of water containing bleach after they leave an Ebola isolation facility during an Ebola simulation at Biankouma Hospital in Côte d’Ivoire. Credit: Marc-André Boisvert/IPSBy Lyndal RowlandsUNITED NATIONS, Dec 23 2016 (IPS)A new Ebola vaccine may be the first to successfully protect against one of the world’s most lethal pathogens, according to a trial involving over 11,000 participants in Guinea.The results of the trial – which was led by the World Health Organization together with Guinea’s Ministry of Health, Medecins sans Frontieres ...
Source: IPS Inter Press Service - Health - December 23, 2016 Category: Global & Universal Authors: Lyndal Rowlands Tags: Featured Headlines Health ebola gui Médicins San Frontiéres (MSF) WHO Source Type: news

Final trial results confirm Ebola vaccine provides & #39high protection & #39 & #8211 UN health agency
The United Nations World Health Organization (WHO) has said that an experimental Ebola vaccine has been found to be highly protective against the deadly virus in a major trial in Guinea. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - December 23, 2016 Category: Global & Universal Source Type: news

Guinea trial shows " historic " success for Ebola vaccine
A vaccine developed by Merck is the first shown to be highly effective in preventing human infection with Ebola, according to final results from a clinical trial. (Source: the Mail online | Health)
Source: the Mail online | Health - December 23, 2016 Category: Consumer Health News Source Type: news

Ebola Vaccine Highly Effective in Phase III Trials (CME/CE)
(MedPage Today) -- Could be deployed if outbreak resumes, investigators say (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - December 23, 2016 Category: American Health Source Type: news

Ebola vaccine is highly effective, final test results confirm
Finaltest results confirm an experimental Ebola vaccine is highly effective, a major milestone that could help prevent the spread of outbreaks like the one that killed thousands in West Africa.Scientists have struggled to develop an Ebola vaccine over the years, and this is the first one proven... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - December 23, 2016 Category: Science Authors: Associated Press Source Type: news

Scientists Create Effective Ebola Vaccine, Just A Couple Years After Deadly Epidemic
Researchers have crafted an effective vaccine that can halt the horrifically deadly Ebola virus in its tracks, according to a new report published Thursday by leading global health organizations. The experimental vaccine ― which has not yet been approved by any regulatory authority ― has already completed successful trials in Sierra Leone and Guinea, among the hardest hit countries during the epidemic. Not a single subject given the vaccine developed Ebola, according to research published in The Lancet by scientists from the World Health Organization, the Norwegian Institute of Public Health and other groups....
Source: Healthy Living - The Huffington Post - December 23, 2016 Category: Consumer Health News Source Type: news

'Phenomenal news': Large clinical trial confirms Ebola vaccine is highly effective
An experimental Ebola vaccine partially designed at Canada's National Microbiology Laboratory was found to be highly protective in a major clinical trial in Guinea, suggesting future outbreaks could be easily contained. (Source: CBC | Health)
Source: CBC | Health - December 23, 2016 Category: Consumer Health News Tags: News/Health Source Type: news

Final trial results confirm Ebola vaccine provides high protection against disease
An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results of a new study. The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 23, 2016 Category: Science Source Type: news

Guinea trial shows 'historic' success for Ebola vaccine
LONDON (Reuters) - A vaccine developed by Merck is the first shown to be highly effective in preventing human infection with Ebola, according to final results from a clinical trial. (Source: Reuters: Health)
Source: Reuters: Health - December 23, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

New Ebola Vaccine Gives 100 Percent Protection
After decades of trying, scientists have finally devised a powerful vaccine against a terrifying contagion. (Source: NYT Health)
Source: NYT Health - December 23, 2016 Category: Consumer Health News Authors: DONALD G. McNEIL Jr. Tags: Ebola Virus Vaccination and Immunization Epidemics Africa The Lancet Guinea Kieny, Marie-Paule World Health Organization Source Type: news

Ebola vaccine shown to be ‘ highly protective ’ against deadly virus in major trial
Scientists on Thursday announced a milestone in the fight against Ebola, reporting that a major trial of an experimental vaccine shows that it may be “highly protective” against the virus, which has infected nearly 30,000 people and killed 11,000 worldwide since 2013. Although the current outbreak has been contained, health officials fear the deadly pathogen could come back and […]Related:Mystery of the spike in deaths between Christmas and New Year’s gets curiouser and curiouserCDC sends $184 million in Zika funding to states as Texas reports new caseMedical detectives raced to...
Source: Washington Post: To Your Health - December 23, 2016 Category: Consumer Health News Source Type: news

Ebola Vaccine Highly Efficacious in Preventing Infection (FREE)
By Amy Orciari Herman Edited by Andr é Sofair, MD, MPH, and William E. Chavey, MD, MS An experimental vaccine was 100% efficacious in preventing Ebola infection in the contacts of patients with confirmed disease, according to final results from a trial conducted in … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 23, 2016 Category: Primary Care Source Type: news

In Cholera Outbreaks, A Single Vaccine Dose Can Work As Well As The Standard Two
A child is vaccinated against cholera in Juba, South Sudan. Credit: UN Photo/JC McIlwaine Oral cholera vaccines are typically administered in two doses, but experience and recent research reveal this may not always be the best approach. Faced with an outbreak in South Sudan, epidemiologist Andrew Azman and his colleagues encountered a difficult decision: vaccinate as many people as possible with a single dose, or fewer with the standard two. Based on emerging research, they chose the first option and found that for the kind of short-term protection needed to stop an outbreak, a single dose works as well. ResearchGate: H...
Source: Science - The Huffington Post - December 20, 2016 Category: Science Source Type: news

Surviving the Tidal Wave
Disease is getting more complex, development costs are skyrocketing and payers are demanding value-based, real-world assessment to counter the rising cost of healthcare – the dilemma facing pharma is well known.Following the publication of a new report,Facing the Tidal Wave, a Partner at Deloitte, Hanno Ronte,  shares some of the emerging strategies that pharma can employ to manage risk and simultaneously pursue innovation in drug development.A tidal wave?The healthcare equivalent of global warming, the tidal wave Deloitte refers to is the growing complexity of disease. In the past decades, pharma has been very ...
Source: EyeForPharma - December 8, 2016 Category: Pharmaceuticals Authors: Dr Nicola Davies Source Type: news

Johnson & Johnson Announces World Health Organization will Review Ebola Vaccine Regimen for Emergency Use Assessment and Listing (EUAL)
Preparations also underway to initiate first-in-human study for multivalent vaccine regimen to combat Ebola, Sudan and Marburg viruses (Source: Johnson and Johnson)
Source: Johnson and Johnson - November 21, 2016 Category: Pharmaceuticals Source Type: news

Aethlon ’ s blood filtration device as broad countermeasure for infectious diseases
In the midst of a devastating global crisis 2 years ago, a Ugandan physician was infected with Ebola in Sierra Leone as he was treating patients. He was hospitalized at the Frankfurt University Hospital and 12 days later he was unconscious, suffering from multiple organ failure. By the time Aethlon Medical (NSDQ:AEMD) got permission to use its Hemopurifier device, the doctor required mechanical ventilation, continuous dialysis and vasopressor medications. After almost 7 hours of treatment with the single cartridge blood filtration device, the patient’s viral load dropped from 400,000 virus copies per milliliter ...
Source: Mass Device - November 18, 2016 Category: Medical Equipment Authors: Sarah Faulkner Tags: Blood Management Food & Drug Administration (FDA) Research & Development Aethlon Medical Inc. MassDevice Q&A Source Type: news

Holding My Breath: Life After Being Diagnosed With TB
In August, I was diagnosed with tuberculosis, an infection that is responsible for more deaths around the world than any other. There was a catch though--it is a latent infection, meaning that it is not spreading nor is it contagious. But if it becomes active, it could be transmitted to my children, my husband and even someone sitting next to me on a plane. Tuberculosis, or TB, is a disease that should be long gone; the bacteria has been found in Egyptian mummies. And yet, TB kills more people today than any other infectious disease in the world: 1.8 million people in 2015, according to an announcement last week by the Wo...
Source: Healthy Living - The Huffington Post - November 12, 2016 Category: Consumer Health News Source Type: news

Are Outbreaks of Infectious Disease Accelerating Around the World?
By Drs. David Niesel and Norbert Herzog It seems that every time we look up, we hear about another infectious disease threatening people somewhere in the world. We really pay attention to the exotic threats - like Ebola and Zika that tend to get heavy media coverage. But sometimes we forget some of the common diseases that occur periodically like outbreaks of measles or the yearly influenza outbreak. Recently, the Zika virus spread throughout South and Latin America, Mexico and Puerto Rico with its devastating effects on the newborn. We are all holding our breath, as Zika has the potential to spread along the Gulf Coas...
Source: Science - The Huffington Post - November 9, 2016 Category: Science Source Type: news

Discovery's Edge: Foreseeing the future of vaccines
Since the first vaccine paved the way for the near-eradication of smallpox over 200 years ago, societies have looked to vaccines as a means to stop the spread of infectious diseases. Today the same concepts are being called upon for new disease threats including Ebola and Middle East respiratory syndrome (MERS),?and the continued reemergence of [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 8, 2016 Category: Databases & Libraries Source Type: news

Zika's Rapid Rise and the Limp Global Response Reveal Dire Global Health Challenges
With cases rising in Florida, Singapore, Vietnam and Trinidad and Tobago, the Zika virus pandemic is raising public concern in regions across the globe, including the U.S., where about 80 percent of Americans are aware of it but only 40 percent understand how it is actually transmitted. This raises a host of questions not only about the clinical and epidemiological scope of the outbreak, but also about the ability of citizens, public health authorities and politicians at all levels to adequately deal with it.  So far, the response has been slow and the challenge remains serious and unpredictable. We need to understand...
Source: Science - The Huffington Post - November 4, 2016 Category: Science Source Type: news

BARDA awards contract to NewLink Genetics for Ebola vaccine development
The Biomedical Advanced Research and Development Authority (BARDA) of the US Department of Health and Human Services (HHS) has awarded a $24.8 million contract to a NewLink Genetics subsidiary to support the development of rVSV ∆G-ZEBOV GP (Ebola Zair… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 6, 2016 Category: Pharmaceuticals Source Type: news